• Complete Blood Cell Count (CBC) with Differential
  • TYMS (Thymidylate Synthetase) Gene Mutation Analysis
  • The Papanicolaou Test (PAP Smear)
  • Herpesvirus 6 (HHV-6) Antibody, IgM
  • Ribonucleoprotein P (U1RNP) Antibody (ENA)
  • 17-Hydroxyprogesterone, Amniotic fluid
  • Dexamethasone Suppression Test (High Dose)
  • Bartonella, Culture
  • Gabapentin, Urine
  • Hereditary Hearing Loss Gene Panel
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Circulating Tumor Cells (CTC), Prostate Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Circulating Tumor Cells (CTC), Prostate Cancer
Medical Test

Clinical Utility
Access to Circulating Tumor Cells (CTC), Prostate Cancer is restricted.